Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles & Nanoparticle-based Therapeutics Europe 2023

Natalia Gebara's Biography



Natalia Gebara, Application Scientist, NanoFCM Co., Ltd.

She obtained her degree in BSc Biochemistry at Nottingham Trent University with thesis titled: Genetic differences in extracellular vesicles derived from therapy resistant cancer cells. She received with a practical diploma by undertaking a year-long internship in Centre for Medical Applied Research in Spain, working with extracellular vesicles in cardiovascular diseases. In 2022 she graduated with a PhD degree in Medical Pathophysiology from University of Turin, as a part of Marie-Curie Horizon 2020 project investigating the role of extracellular vesicles in feto-maternal health. In September 2020 she joined NanoFCM Co., Ltd.to work as a part of a team focused on nanoparticle research and commercialization of the NanoAnalyzer.

Natalia Gebara Image

NanoFCM Brings Flow Cytometry Capabilities to the Nanoscale!

Monday, 13 November 2023 at 11:45

Add to Calendar ▼2023-11-13 11:45:002023-11-13 12:45:00Europe/LondonNanoFCM Brings Flow Cytometry Capabilities to the Nanoscale!Extracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Conventional flow cytometers often struggle to meet the sensitivity requirements for the analysis of nanoscale particles, such as exosomes, nanomedicine, and viruses. To meet this challenge, NanoFCM has developed the NanoAnalyzer, a dedicated nano-flow cytometry platform, which offers a flexible and high-throughput solution for sub-micron analysis. By using the NanoAnalyzer, single-particle characterization can be achieved which simultaneously measures the side scatter (40 -1000nm) and fluorescent properties of particles. The size detection of the NanoAnalyzer favorably compares to electron microscopy and covers the entire size range of EVs, offering a detailed analysis of size, concentration, and biochemical properties by direct correlation of the physical and phenotypic data.  It is by combination of all these properties that the NanoAnalyzer is an ideal next-generation technique/ instrument for the analysis of EVs.


Add to Calendar ▼2023-11-13 00:00:002023-11-14 00:00:00Europe/LondonExtracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023Extracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com